[go: up one dir, main page]

Loomes et al., 2007 - Google Patents

Dll3 and Notch1 genetic interactions model axial segmental and craniofacial malformations of human birth defects

Loomes et al., 2007

View PDF @Full View
Document ID
5031106762897239948
Author
Loomes K
Stevens S
O'Brien M
Gonzalez D
Ryan M
Segalov M
Dormans N
Mimoto M
Gibson J
Sewell W
Schaffer A
Nah H
Rappaport E
Pratt S
Dunwoodie S
Kusumi K
Publication year
Publication venue
Developmental dynamics: an official publication of the American Association of Anatomists

External Links

Snippet

Mutations in the Notch1 receptor and delta‐like 3 (Dll3) ligand cause global disruptions in axial segmental patterning. Genetic interactions between members of the notch pathway have previously been shown to cause patterning defects not observed in single gene …
Continue reading at anatomypubs.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Similar Documents

Publication Publication Date Title
Loomes et al. Dll3 and Notch1 genetic interactions model axial segmental and craniofacial malformations of human birth defects
Watanabe et al. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype
Pilliod et al. New practical definitions for the diagnosis of autosomal recessive spastic ataxia of C harlevoix–S aguenay
Gusella et al. Huntington's disease: seeing the pathogenic process through a genetic lens
McDonald-McGinn et al. 22q11. 2 deletion syndrome
Zhang et al. Dosage effects of cohesin regulatory factor PDS5 on mammalian development: implications for cohesinopathies
Khanna et al. A review of genetic factors contributing to the etiopathogenesis of anorectal malformations
Heanue et al. A novel zebrafish ret heterozygous model of Hirschsprung disease identifies a functional role for mapk10 as a modifier of enteric nervous system phenotype severity
Roessler et al. Cumulative ligand activity of NODAL mutations and modifiers are linked to human heart defects and holoprosencephaly
Crespi Genomic imprinting in the development and evolution of psychotic spectrum conditions
Green et al. Tfap2a-dependent changes in mouse facial morphology result in clefting that can be ameliorated by a reduction in Fgf8 gene dosage
Zollino et al. Unusual 4p16. 3 deletions suggest an additional chromosome region for the Wolf‐Hirschhorn syndrome–associated seizures disorder
Xiong et al. Mutation in SSUH2 causes autosomal‐dominant dentin dysplasia type I
Kim et al. Neuronal functions of FOXO/DAF-16
Raveau et al. Brain ventriculomegaly in Down syndrome mice is caused by Pcp4 dose-dependent cilia dysfunction
Yang et al. Analysis of PRICKLE 1 in human cleft palate and mouse development demonstrates rare and common variants involved in human malformations
Delprato et al. Systems genetic analysis of hippocampal neuroanatomy and spatial learning in mice
Zhang et al. Autism spectrum disorders: autistic phenotypes and complicated mechanisms
Cristofoli et al. Novel CASK mutations in cases with syndromic microcephaly
Liu et al. Association of rare recurrent copy number variants with congenital heart defects based on next-generation sequencing data from family trios
Chen et al. A reduction in Ptprq associated with specific features of the deafness phenotype of the miR‐96 mutant mouse diminuendo
Kang et al. CYFIP2 p. Arg87Cys causes neurological defects and degradation of CYFIP2
KR20140094511A (en) Screening method
Du et al. SH2B1 tunes hippocampal ERK signaling to influence fluid intelligence in humans and mice
Gaglani et al. The genetic control of neocortex volume and covariation with neocortical gene expression in mice